Introduction on Jiangxi Neo-green Pharmaceutical Technology Development Co., Ltd.

1. Introduction

Jiangxi Neo-green Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as Jiangxi NGP) established in April, 2019. It is the wholly - funded branch of Sichuan NGP and was rated as the key project in Jiangxi Province in 2020, with the registered capital of 100 billion yuan. It is a specialized enterprise integrating planting, process, scientific research, manufacture and trade of TCM materials and is mainly engaged in the production and operation of granules, capsules, pills, tablets and TCM decoction pieces.   

2. Enterprise Scale

Jiangxi Neo-green Pharmaceutical Technology Development Co., Ltd. is located in the "modern traditional Chinese medicine production base of new green traditional Chinese medicine industry" at No. 399, Cigu Road, chuangcheng, traditional Chinese medicine, Ganjiang New District, directly under the jurisdiction of Jiangxi Province. Jiangxi NGP has had an area of 201 mu with the gross investment of 1.25 billion yuan. The phase Ⅰ construction was started in August, 2019 and finished in December, 2020, with an area of 40,000 m². It mainly including extraction workshop, formula particle workshop, quality inspection center, traditional Chinese Medicine Museum, sewage treatment plant and shift dormitory building have been completed and put into trial operation.

3. Enterprise Development

Relying on the powerful scientific research technological team of the group, Jiangxi NGP has built quantizable quality management index system and realized the industrialization, standardization and modernization of TCM formula granule by applying modern pharmaceutical technology. The company has realized automatic control during the manufacture process by introducing in automatic control system, low-temperature concentration system and spray dying system of advanced manufacture equipment. The company has had an annual production capacity of 1,000 tons TCM decoction pieces and 1,000 tons TCM formula granules, which shall make it the production base with higher intelligent level for TCM formula granule in the East China. It is expected to be out into production in the end of 2023 with the maximum production value of 1 billion yuan.     

The growth and expansion of modern traditional Chinese medicine enterprises is the epitome of the rise of national traditional Chinese medicine. We are willing to be the forerunner of the four modernizations of traditional Chinese medicine, contribute our strength to the rise of national medicine, feel glory in the progress and create innovation in the challenge. The vision of our enterprise is to "consolidate the root of health, build the foundation of science and technology and promote the light of national quintessence". Our enterprise is determined to take root in the innovation city of traditional Chinese medicine in Ganjiang new area, Jiangxi Province and be a pioneer in leading the modernization of Traditional Chinese Medicine.